GGrantIndex
Sort

261,768 grants matching gene therapy

Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit

$913,759
Melanie Beth Fried-Oken · Oregon Health & Science University · R01 · FY2024 · DC

Aberrant protein S-nitrosylation mediates Gene-Environment Interactions in AD/ADRD

$913,756
Stuart A Lipton · Scripps Research Institute, The · U01 · FY2024 · AG

Reservoir depletion and anti-retroviral therapy for infant functional cure

$913,753
Dennis J Hartigan-O'Connor · University Of California At Davis · R01 · FY2017 · AI

Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1

$913,621
Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

University of Washington Obstetric-fetal Pharmacology Research Unit

$913,610
Mary F Hebert · University Of Washington · U10 · FY2014 · HD

Blocking HIV with aptamers targeted to viral components

$913,516
Vinayaka R Prasad · Albert Einstein College Of Medicine · P01 · FY2007 · AI

Collaborative Expansion of Marmoset Colonies for Neuroscience Research

$913,417
Jon E Levine · University Of Wisconsin-Madison · U24 · FY2023 · MH

Commercialization of Human Mesothelial Cells for Research

$913,158
Yolanda Renee Lea-Currie · Zen-Bio, Inc. · R44 · FY2009 · RR

Project 3: Effect of Age and Longevity Genes on Epigenomic Mechanisms

$913,103
Joseph C Wu · Stanford University · P01 · FY2011 · GM

Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis

$913,097
Scott Scarneo · Eydis Bio, Inc. · R44 · FY2022 · AR

The Impact of Epstein Barr Virus Infection on the Immune Response in Pediatric Transplant Recipients

$913,096
Olivia M Martinez · Stanford University · U01 · FY2019 · AI

Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction

$913,077
Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA

Assessing the mechanisms underlying female sex-predominance in Long COVID

$913,012
Michael Joseph Peluso · University Of California, San Francisco · R01 · FY2025 · AI

Determining the Fate of Transmembrane Proteins

$913,002
Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

The mTOR and Hippo pathway in cell growth and cancer

$912,964
Kun-Liang Guan · University Of California, San Diego · R35 · FY2017 · CA

The mTOR and Hippo pathway in cell growth and cancer

$912,964
Kun-Liang Guan · University Of California, San Diego · R35 · FY2016 · CA

Cocaine Addiction and the Role of Serotonin in Orbitofrontal Cortex Function

$912,950
Carl Lupica · National Institute On Drug Abuse · ZIA · FY2023 · DA

Precision Medicine in Sarcoidosis

$912,947
Jeffrey R Jacobson · University Of Illinois At Chicago · R01 · FY2021 · HL

Ca2+ signaling Networks in Health and Disease

$912,947
Mohamed Trebak · University Of Pittsburgh At Pittsburgh · R35 · FY2022 · HL

Entry and replication of positive-sense, RNA viruses

$912,922
Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings

$912,858
Rafael Guerrero-Preston · Lifegene-Biomarks, Inc. · R44 · FY2025 · CA

Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas

$912,796
Darell D Bigner · Duke University · R35 · FY2018 · CA

Therapeutic Targeting of Human AML Stem Cells

$912,708
Craig T. Jordan · University Of Colorado Denver · R35 · FY2022 · CA

Phase 2 Clinical Trials Program for Experimental Therapeutics Clinical Trials Network

$912,510
Alex A Adjei · Mayo Clinic Rochester · UM1 · FY2016 · CA

Aging Intervention Program

$912,434
Rafael De Cabo · National Institute On Aging · ZIA · FY2025 · AG